Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Lrrk2 Inhibitors: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| LRRK2 | inhibits | protein | 0.95 |
| Lysosomal Function | treats | process | 0.85 |
| α-Synuclein Accumulation | associated_with | process | 0.85 |
| Sporadic Parkinson'S Disease | treats | disease | 0.85 |
| Neurodegeneration | protects_against | process | 0.85 |
| Neurodegeneration | suppresses | process | 0.80 |
| Lysosomal Function | associated_with | process | 0.80 |
| Parkinson's Disease | treats | disease | 0.75 |
| Parkinson disease | therapeutic_target_for | disease | 0.70 |
| LRRK2 | inhibits | protein | 0.70 |
| Parkinson's disease | treats | disease | 0.70 |
| lysosomal defects | inhibits | mechanism | 0.70 |
| Parkinson's disease | therapeutic_target_for | disease | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-27 | 0 hypotheses
neurodegeneration | 2026-04-15 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
active · Rounds: 6 · Score: 0.89 · 2026-04-27
closed · Rounds: 4 · Score: 0.95 · 2026-04-16
Hypotheses and analyses mentioning Lrrk2 Inhibitors in their description or question text
No additional research found